Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis
Condition(s):Breast CancerLast Updated:March 10, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:March 10, 2023Completed
Condition(s):Advanced Breast CancerLast Updated:November 24, 2023Active, not recruiting
Condition(s):Breast CancerLast Updated:March 21, 2024Active, not recruiting
Condition(s):Breast CancerLast Updated:November 1, 2022Withdrawn
Condition(s):Breast Cancer, MaleLast Updated:January 25, 2024Completed
Condition(s):Breast CancerLast Updated:January 5, 2021Completed
Condition(s):Breast CancerLast Updated:November 7, 2022Not yet recruiting
Condition(s):Breast NeoplasmsLast Updated:March 9, 2023Recruiting
Condition(s):Breast CancerLast Updated:April 4, 2023Completed
Condition(s):Breast Cancer; Metastasis to Liver; Metastasis to LungLast Updated:May 4, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.